Dengue Study

Prospective dengue sero-prevalence Study in 5- to 10-Year-old children in India – A community based descriptive cross sectional study

Overview

Open the "Settings" panel to insert HTML code.

Status of the project

This study was conducted geographically distinct sites across India and SHARE INDIA implemented this study in 2 sites to determine the prevalence of specific antibodies (immunoglobulin G, IgG) against Dengue in healthy 5 to 10 year-old children in India under the sponsorship of Sanofi Pasteur. This study was conducted in 8 Overall, Dengue IgG prevalence in the SHARE INDIA implementation sites was 58%. The proportion of seropositive subjects did not differ according to sex but differed according to age. Dengue IgG prevalence was higher in 8-10 year th old than in 5-7 year-old subjects.

Investigators

Dr. Ganesh Oruganti, Director Public Health, SHARE INDIA.

Dr. Enakshi Ganguly, Associate Professor, Department of Community Medicine, MediCiti Institute of Medical Sciences.

Dr. Jammy Guru Rajesh, Tutor, Department of Community Medicine, MediCiti Institute of Medical Sciences.

Funding sources

Sanofi Pasteur, France